These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A; Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024 [TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348 [TBL] [Abstract][Full Text] [Related]
4. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F; Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723 [TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635 [TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season. Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046 [TBL] [Abstract][Full Text] [Related]
7. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy. Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847 [No Abstract] [Full Text] [Related]
8. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728 [TBL] [Abstract][Full Text] [Related]
9. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661 [TBL] [Abstract][Full Text] [Related]
10. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A; Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681 [TBL] [Abstract][Full Text] [Related]
11. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662 [TBL] [Abstract][Full Text] [Related]
12. On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region. Colucci ME; Veronesi L; Bracchi MT; Zoni R; Caruso L; Capobianco E; Rossi D; Bizzarro A; Cantarelli A; Affanni P Acta Biomed; 2019 Sep; 90(9-S):21-27. PubMed ID: 31517886 [TBL] [Abstract][Full Text] [Related]
13. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051 [TBL] [Abstract][Full Text] [Related]
15. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study. Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266 [TBL] [Abstract][Full Text] [Related]
16. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A; Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713 [TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season. Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study. Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M; Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ; Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911 [TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J; Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]